Deutsche Bank

Deutsche Bank’s Biodexa Pharmaceuticals BDRX Stock Holding History

Deutsche Bank’s Portfolio BDRX Stock Details BDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Hold	0	–	-$76K	–	4536
2020 Q4	–	Hold	0	–	–	–	3989
2020 Q1	–	Hold	0	–	-$6K	–	4355
2019 Q4	–	Hold	0	–	–	–	4612
2019 Q3	–	Hold	0	–	–	–	4883
2019 Q2	–	Hold	0	–	–	–	5283
2019 Q1	–	Hold	0	–	–	–	4156
2018 Q4	–	Hold	0	–	–	–	5091
2018 Q2	–	Hold	0	–	–	–	5407
2018 Q1	–	Hold	0	–	–	–	5391
2016 Q3	–	Hold	0	–	–	–	4909
2016 Q2	–	Hold	0	–	–	–	5171
2016 Q1	–	Hold	0	–	–	–	5151
2015 Q4	–	Hold	0	–	–	–	5266

Other funds holding BDRX

Renaissance Technologies

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Lombard Odier Asset Management (USA)

Lombard Odier Asset Management (USA) New York $727M AUM 41.88% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Virtu Financial

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Spire Wealth Management

Spire Wealth Management Mclean, Virginia $3.27B AUM 30.11% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return